A number of commercial clinical genetic panels, using next generation sequencing, are available to investigate HTX, laterality disorders, congenital heart defects, primary ciliary dyskinesia, non-motile ciliopathies, situs inversus, and other clinical concerns. The gene discussed is ZIC3; the disease is congenital heart disease.